Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000506722 | SCV000601321 | pathogenic | not provided | 2017-04-20 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001255596 | SCV001432104 | pathogenic | Beta thalassemia intermedia | 2022-11-23 | criteria provided, single submitter | clinical testing | Variant summary: HBB c.-81A>G (also known as c. -31A>G) is located in the untranscribed region upstream of the HBB gene region. The variant was absent in 31390 control chromosomes (gnomAD). c.-81A>G has been reported in the literature in multiple individuals (mostly of Japanese origin) affected with Beta Thalassemia Intermedia (e.g. Takihara_1986, Hattori_1989, Ohba_1997, Fucharoen_1990). These data indicate that the variant is very likely to be associated with disease. In a functional assay, this variant resulted in reduced beta-globin RNA levels (Takihara_1986). Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. |
Invitae | RCV000506722 | SCV001589195 | pathogenic | not provided | 2022-11-10 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Studies have shown that this variant alters HBB gene expression (PMID: 3002527). ClinVar contains an entry for this variant (Variation ID: 15466). This variant is also known as -31A>G. This variant has been observed in individual(s) with beta thalassemia (PMID: 2634674, 3002527, 26029792). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is not present in population databases (gnomAD no frequency). This variant occurs in a non-coding region of the HBB gene. It does not change the encoded amino acid sequence of the HBB protein. |
OMIM | RCV000016724 | SCV000036994 | pathogenic | Beta-plus-thalassemia | 1989-01-01 | no assertion criteria provided | literature only | |
Gene |
RCV000445643 | SCV000537288 | not provided | beta Thalassemia | no assertion provided | literature only | ||
The ITHANET community portal, |
RCV000445643 | SCV001244529 | pathogenic | beta Thalassemia | 2019-11-25 | no assertion criteria provided | curation | |
Natera, |
RCV000445643 | SCV002091632 | pathogenic | beta Thalassemia | 2017-03-17 | no assertion criteria provided | clinical testing | |
Molecular Genetics Laboratory, |
RCV000445643 | SCV002754540 | pathogenic | beta Thalassemia | 2022-05-11 | no assertion criteria provided | clinical testing |